400 Dexter Ave N Ste 1200, Seattle, Washington, 98109, United States
Clinical-stage company developing breakthrough immunotherapies for cancer.
Total Raised
$310 M
Rounds
4
Links
Verticals
Series B
Aug 2014
$134M
Series A
Apr 2014
$31M
Jan 2014
$25M
Dec 2013
$120M
Hans Bishop
Co-Founder & CEO
Isabelle Rivière
Scientific & Co-Founder
Stan Riddell
Scientific Co-Founder
Michel Sadelain
